
David H. Sachs MD
Clinical & Laboratory Immunology
Professor, Surgery, Massachusetts General Hospital, Harvard Medical School
Join to View Full Profile
Bldg. 149-9019, 13th StreetBoston, MA 02129
Phone+1 617-726-4065
Fax+1 617-726-4067
Dr. Sachs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Massachusetts General HospitalInternship, Transitional Year, 1968 - 1969
- Harvard Medical SchoolClass of 1968
Certifications & Licensure
- MA State Medical License 1987 - 2026
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1996
Clinical Trials
- Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant Start of enrollment: 2003 Jun 01
- Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection Start of enrollment: 2008 Dec 01
- Renal Allograft Tolerance Through Mixed Chimerism Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance.Helen Stark, Quan Yao Ho, Amy Cross, Alessandro Alessandrini, Alice Bertaina
Transplantation. 2025-04-01 - Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease.Tatsuo Kawai, Winfred W Williams, Nahel Elias, Jay A Fishman, Kerry Crisalli
The New England Journal of Medicine. 2025-02-07 - Vascular endothelial cells derived from transgene-free pig induced pluripotent stem cells for vascular tissue engineering.Luke Batty, Jinkyu Park, Lingfeng Qin, Muhammad Riaz, Yuyao Lin
Acta Biomaterialia. 2025-01-24
Journal Articles
- Ontak-like Human IL-2 Fusion ToxinDavid H. Sachs, Joren C. Madsen, Joren C Madsen, David H Sachs, ScienceDirect
Press Mentions
- Healthy ConversationsMarch 23rd, 2022
- UCLA Health Advances Pioneering Protocol to Enable Transplant Recipients to Thrive Without Antirejection DrugsFebruary 1st, 2022
- Four Breakthroughs That Led to the Pig Heart TransplantJanuary 18th, 2022
- Join now to see all
Grant Support
- A Tolerance Approach to XenotransplantationCOLUMBIA UNIVERSITY HEALTH SCIENCES2000–2026
- A Tolerance Approach to XenotransplantationCOLUMBIA UNIVERSITY HEALTH SCIENCES2000–2026
- A Tolerance Approach to XenotransplantationCOLUMBIA UNIVERSITY HEALTH SCIENCES2000–2026
- A Tolerance Approach to XenotransplantationCOLUMBIA UNIVERSITY HEALTH SCIENCES2000–2026
- A Tolerance Approach to XenotransplantationCOLUMBIA UNIVERSITY HEALTH SCIENCES2000–2026
- A Tolerance Approach to XenotransplantationCOLUMBIA UNIVERSITY HEALTH SCIENCES2000–2026
- Composite porcine islet-kidney xenotransplants to cure diabetes and renal failureCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
- Thymic Rejuvenation For The Induction Of Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2010–2012
- Galt-Ko Pigs Expressing Primate CD47 To Facilitate Organ XenograftsNational Institute Of Allergy And Infectious Diseases2010–2011
- Tolerance To Composite Islet-Kidney Transplants In BaboonsNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Tolerance To Vascularized Allografts In MiniswineNational Institute Of Allergy And Infectious Diseases2006–2011
- Training In Transplantation BiologyNational Institute Of Allergy And Infectious Diseases1998–2011
- Genetics And Mechanisms Of DLI Effects Following Non-Myeloblative HCTNational Cancer Institute2010
- Genetics And Mechanisms Of DLI Effects Following Non-Myeloblative HCTNational Cancer Institute2006–2009
- Islet-Kidney Transplants For Treatment Of Diabetic ESRDNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Tolerance To Vascularized Allografts In MiniswineNational Institute Of Allergy And Infectious Diseases1996–2005
- Islet-Kidney Transplants For Treatment Of Diabetic ESRDNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
- Mixed Chimerism In Miniature SwineNational Cancer Institute2000–2002
- Mixed Hematopoietic Cell Chimerism In A ModelNational Heart, Lung, And Blood Institute1999–2002
- Tolerance To Heart Transplants In Miniature SwineNational Heart, Lung, And Blood Institute1998–2002
- Thymus TransplantationNational Institute Of Allergy And Infectious Diseases1996–2002
- Bone Marrow Culture And Engraftment In A Swine ModelNational Heart, Lung, And Blood Institute1995–1999
- Transplantation Of T Cell-Depleted Marrow In MiniswineNational Cancer Institute1994–1997
- Retroviral Transduction Of Class I MHC GeneNational Heart, Lung, And Blood Institute1993–1997
- Tolerance To Vascular AllograftsNational Institute Of Allergy And Infectious Diseases1994–1995
- Bone Marrow Transplantation Across MHC BarriersNational Cancer Institute1992–1994
- Bone Marrow Culture And Engraftment In A ModelNational Heart, Lung, And Blood Institute1991–1994
- Tolerance To Vascular Allografts In Miniature SwineNational Institute Of Allergy And Infectious Diseases1991–1993
- A Flexible Scheduling Program For Longitudinal StudiesNational Institute On Drug Abuse1991
- Optimum Dose And Schedule For Nicotine Gum TreatmentNational Institute On Drug Abuse1988–1991
- A Flexible Scheduling Program For Longitudinal StudiesNational Institute On Drug Abuse1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: